Opioid Hypermetabolism in a Multiextremity Spine Trauma Patient: A Case Report

Area of Science:

• Pharmacogenomics
• Musculoskeletal Trauma
• Pain Management

Background:

• Opioid analgesics are standard for managing severe pain.
• Individual responses to opioids vary significantly.
• Genetic factors, such as cytochrome P450 2D6 (CYP2D6) polymorphisms, influence drug metabolism.

Purpose of the Study:

• To investigate the role of CYP2D6 genotype in pain management challenges.
• To highlight the potential impact of genetic variations on opioid efficacy in trauma patients.

Main Methods:

• Case report of a 17-year-old male with severe injuries (C5 flexion-compression, distal radius fractures).
• Standard opioid therapy was administered.
• Genetic testing was performed to identify polymorphisms in the CYP2D6 gene.

Main Results:

• The patient exhibited ultrarapid metabolism due to a CYP2D6 polymorphism.
• Despite standard opioid treatment, the patient experienced significant difficulty with pain control.
• This suggests a correlation between CYP2D6 ultrarapid metabolism and reduced opioid efficacy.

Conclusions:

• CYP2D6 genetic mutations can impair opioid metabolism and lead to inadequate pain relief.
• Clinicians should consider CYP2D6 mutations in patients with persistent pain despite adequate opioid doses.
• Personalized pain management strategies, informed by pharmacogenetics, are crucial for optimal patient outcomes in trauma care.